Dana­her ap­proached con­tract man­u­fac­tur­er Catal­ent about ac­qui­si­tion – re­port

3 years ago
Deals
Manufacturing

DC ap­peals court re­vives case ac­cus­ing phar­mas of fi­nanc­ing ter­ror at­tacks

3 years ago
Pharma
Law

Bris­tol My­ers de­buts first pso­ri­a­sis drug ad on Gram­mys, lead­ing cho­rus of phar­ma brands

3 years ago
Pharma
Marketing

Sanofi re­sponds to patent spat with Am­gen as Supreme Court ar­gu­ments set for March

3 years ago
Pharma
Law

'S­mooth and very much on track': Ei­sai re­ports first ship­ments of Leqem­bi

3 years ago
Pharma

A long­time track­er on phar­ma R&D pro­duc­tiv­i­ty takes a post-pan­dem­ic plunge back to a bleak re­al­i­ty

3 years ago
Bioregnum
R&D

Up­dat­ed: Biden's sci­ence team sees an­oth­er mi­ni-tran­si­tion as Alon­dra Nel­son de­parts

3 years ago
People
FDA+

Take­da snags ex­pand­ed pe­di­atric ap­proval for rare ge­net­ic dis­or­der drug

3 years ago
Pharma

IgGenix sprints to clin­ic with peanut al­ler­gy can­di­date and ad­di­tion­al $40M

3 years ago
Financing

Ab­b­Vie opens up to big­ger deals as com­pe­ti­tion heats up — re­port; Small ra­dio­phar­ma­ceu­ti­cal play­er goes pub­lic via ...

3 years ago
News Briefing

Epilep­sy and Alzheimer's cell ther­a­py biotech lays off 25% of staff

3 years ago
People
Startups

Sage, Bio­gen set their sights on a sum­mer PDU­FA dead­line as zu­ra­nolone de­ci­sion looms

3 years ago
FDA+

J&J clears PhII for rare blood dis­or­der with drug from $6.5B Mo­men­ta buy­out

3 years ago
R&D
Pharma

Up­dat­ed: R&D tur­bu­lence at Bris­tol My­ers now in­cludes the end of a $650M al­liance and the de­par­ture of a top re­search ...

3 years ago
Bioregnum

Idor­si­a's brain bleed drug flunks PhI­II tri­al, a decade af­ter pre­vi­ous flop

3 years ago
R&D

Astel­las taps chief strat­e­gy of­fi­cer as next CEO to 'go on the ag­gres­sive'

3 years ago
People

Clin­i­cal tri­al di­ver­si­ty da­ta show mis­match be­tween en­roll­ment and dis­ease preva­lence, GSK says

3 years ago
Pharma

The Big Phar­ma dis­card pile; Lay­offs all around while some biotechs bid farewell; New Roche CEO as­sem­bles top team; ...

3 years ago
Weekly

Te­va drops out of in­dus­try trade group PhRMA

3 years ago
Pharma

Sanofi sees downtick in flu sales as it preps for launch of RSV an­ti­body

3 years ago
Pharma

Take­da fo­cus­es on ‘di­verse’ pipeline prospects on heels of two ac­qui­si­tions

3 years ago
Pharma

In show­down with Roche, Re­gen­eron gears up for po­ten­tial Eylea ex­pan­sion amid Covid de­cline

3 years ago
Pharma

In­fla­tion re­bates in­com­ing: Wyden calls on CMS to move quick­ly as No­var­tis CEO pledges re­ver­sal

3 years ago
Pharma
Law

BeiGene re­veals men­tal health and can­cer care gap in study, de­buts dig­i­tal re­sources

3 years ago
Pharma
Marketing
First page Previous page 391392393394395396397 Next page Last page
A service from the Financial Times